Publikationen in Zusammenarbeit mit Forschern von University of Szeged (15)

2022

  1. Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study

    European Urology Open Science, Vol. 40, pp. 38-45

  2. Pharmaceutical and Safety Profile Evaluation of Novel Selenocompounds with Noteworthy Anticancer Activity

    Pharmaceutics, Vol. 14, Núm. 2

2021

  1. Author Correction: A community-based transcriptomics classification and nomenclature of neocortical cell types (Nature Neuroscience, (2020), 23, 12, (1456-1468), 10.1038/s41593-020-0685-8)

    Nature Neuroscience

  2. Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma

    Journal of Clinical Oncology, Vol. 39, Núm. 24, pp. 2656-2666

  3. Pressure injury prediction models for critically-ill patients should consider both the case-mix and local factors

    Intensive and Critical Care Nursing

  4. Publisher Correction: A community-based transcriptomics classification and nomenclature of neocortical cell types (Nature Neuroscience, (2020), 23, 12, (1456-1468), 10.1038/s41593-020-0685-8)

    Nature Neuroscience

  5. The Listening Network and Cochlear Implant Benefits in Hearing-Impaired Adults

    Frontiers in Aging Neuroscience, Vol. 13

2020

  1. A community-based transcriptomics classification and nomenclature of neocortical cell types

    Nature Neuroscience

2019

  1. Antiviral, antimicrobial and antibiofilm activity of selenoesters and selenoanhydrides

    Molecules, Vol. 24, Núm. 23

  2. Organoselenium compounds as novel adjuvants of chemotherapy drugs—a promising approach to fight cancer drug resistance

    Molecules, Vol. 24, Núm. 2

  3. Selenocompounds as novel antibacterial agents and bacterial efflux pump inhibitors

    Molecules, Vol. 24, Núm. 8

  4. Selenoesters and selenoanhydrides as novel agents against resistant breast cancer

    Anticancer Research, Vol. 39, Núm. 7, pp. 3777-3783

2017

  1. Selenoesters and selenoanhydrides as novel multidrug resistance reversing agents: A confirmation study in a colon cancer MDR cell line

    Bioorganic and Medicinal Chemistry Letters, Vol. 27, Núm. 4, pp. 797-802

2016

  1. Identification of selenocompounds with promising properties to reverse cancer multidrug resistance

    Bioorganic and Medicinal Chemistry Letters, Vol. 26, Núm. 12, pp. 2821-2824

2012

  1. Mortality after surgery in Europe: A 7 day cohort study

    The Lancet, Vol. 380, Núm. 9847, pp. 1059-1065